Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells
about
Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo.Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer.Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B.
P2860
Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Dacomitinib, a pan-inhibitor o ...... istant ovarian carcinoma cells
@ast
Dacomitinib, a pan-inhibitor o ...... istant ovarian carcinoma cells
@en
type
label
Dacomitinib, a pan-inhibitor o ...... istant ovarian carcinoma cells
@ast
Dacomitinib, a pan-inhibitor o ...... istant ovarian carcinoma cells
@en
prefLabel
Dacomitinib, a pan-inhibitor o ...... istant ovarian carcinoma cells
@ast
Dacomitinib, a pan-inhibitor o ...... istant ovarian carcinoma cells
@en
P2093
P2860
P50
P1433
P1476
Dacomitinib, a pan-inhibitor o ...... istant ovarian carcinoma cells
@en
P2093
Ardeshir Ghavamzadeh
Azam Zaghal
Farima Moghaddaskho
Farinaz Barghi
Fatemeh Esmaeili
Ghazaleh Sankanian
Ghazaleh Zarrinrad
Haniyeh Eyvani
Hassan Yousefi
Kamran Alimoghaddam
P2860
P2888
P356
10.1038/S41598-017-04147-0
P407
P50
P577
2017-06-23T00:00:00Z
P6179
1086122314